2004Chinese Journal of New Drugs and Clinical RemediesRequires access

Pharmacokinetics of gatifloxacin mesylate tablets in healthy volunteers

Wei Li

Open publisher page 0 citations

Abstract

AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.

About this research paper

What this paper is about

AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To study the pharmocokinetics characteristics of gatifloxacin mesylate tablets in healthy volunteers in order to providing the verification of clinical safety and reasonable application of them. METHODS: Eighteen male subjects received a single oral dose of 400 mg of gatifloxacin mesylate. The plasma concentration of gatifloxacin mesylate was determined by HPLC method. RESULTS: The main pharmacokinetics parameters of gatifloxacin mesylate were as follows: T_ max, C_ max, T__ 12β, AUC_ (0-24) were (1.5±s 0.4) h, (3.4±1.0) mg·L -1,(6.6±1.0) h, (33±10) mg·h·L -1, respectively. CONCLUSION: The pharmacokinetics of gatifloxacin mesylate tablets are similar to those of gatifloxacin hydrochloride. It has advantage of quick absorption, high bioavailability and long mean retention time and inter-individual variability.

Key concepts: Gatifloxacin, Mesylate, Bioavailability, Pharmacokinetics, Pharmacology, Medicine, Chemistry, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of gatifloxacin mesylate tablets in healthy volunteers — Research Paper | ScholarLens